Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -7.35M | $ -1.26 | 1 | 5.82M |
3/31/2025 | $ -4.94M | $ -0.93 | 1 | 5.31M |
12/31/2024 | $ -5.19M | $ -1.53 | 1 | 3.4M |
9/30/2024 | $ -4.53M | $ -1.22 | 1 | 3.71M |
6/30/2024 | $ -2.83M | $ -2.45 | 1 | 1.16M |
3/31/2024 | $ -4.1M | $ -5.82 | 1 | 704.91K |
12/31/2023 | $ -4.15M | $ -34.46 | 1 | 120.43K |
9/30/2023 | $ -5.04M | $ -37.62 | 1 | 134.06K |
6/30/2023 | $ -6.45M | $ -71.05 | 1 | 90.74K |
3/31/2023 | $ -6.31M | $ -108.51 | 1 | 58.14K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for NOVABAY PHARMACEUTICALS INC is calculated as follows: FCF [ $ -4.71M ] / (Shares WA [ 32.68K ] * Share Factor [ 1 ])
(=) FCFPS [ $ -144.11 ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -8.05 |
max | $ 8.91 |
average | $ 0.81 |
median | $ 0.3 |
std | $ 2.83 |